Monthly Archives: October 2010

This fall, graduate students in a nanomedicine course at the University of Texas Health Science Center at Houston (UTHealth) are logging into an online virtual world known as Second Life, activating their computer-generated avatars and heading off to class. This … Continue reading →

Restoring a vital gene in a small part of the brain could well reverse major depression in humans after animals studies demonstrated considerable promise, say researchers from NewYork-Presbyterian Hospital/Weill Cornell Medical Center in an article published in Science Translational Journal, … Continue reading →

A gene therapy treatment that cures mice of depression-like symptoms could be the key to treating the blues in humans, according to a new study. The treatment, which is now being tested in primates, could be approved for human clinical … Continue reading →

By Alla Katsnelson Gene therapy delivered to a specific part of the brain reverses symptoms of depression in a mouse model of the disease–potentially laying the groundwork for a new approach to treating severe cases of human depression in which … Continue reading →

Gene therapy eased symptoms of depression in a mouse study that may spur new research in humans, scientists said.

Researchers have identified a gene that can cause symptoms of major depression and said it may be possible to use gene therapy to counteract its effects

Gene therapy could become a powerful new weapon in the fight against severe depression that does not respond to traditional drug treatments, US researchers said Wednesday.

Researchers say animal and human data suggest gene therapy to the brain may be able to treat patients with major depression who do not respond to traditional drug treatment.

Gene therapy in mice appears to be able to “correct” a gene defect strongly linked to depression in humans.

US doctors have begun the first tests of human embryonic stem cells in patients, treating a man with spinal cord injuries in a landmark trial of the controversial process, the Geron Corporation said Monday.

Australian researchers have developed the country’s first diabetes specific stem cell line, a major advance for patients suffering from the chronic disease.

Researchers announced they had injected embryonic stem cells into a patient suffering from a spinal cord injury.

Heather Allen cradled the IV line in her hands, watching the stream of stem cells snake its way toward her veins. It drew incredulous stares from her family. This was it?

U.S. doctors have begun treating the first patient using human embryonic stem cells as part of the first approved study of the controversial treatment, the Geron Corporation said Monday.

In a landmark trial, researchers have begun using embryonic stem cells to treat a paralyzed patient.

The world is waiting to see how the first major embryonic stem cell trial in humans went, say Aust experts.

Two UC Davis Medical School physicians were awarded $9.7 million in state funding this week to study how stem cells could improve the healing of wounds in diabetics and, in separate research, discover an alternative to liver transplants.

The British media have been hoodwinked by sections of the science community

Researchers announced Monday they had injected embryonic stem cells into a patient suffering from a spinal cord injury. It marked the world’s first human clinical trial of a procedure developed from such a source. The procedure took place at Shepherd … Continue reading →

CMDA’s vice president praises Stanford’s efforts to expand stem cell research with its soon to be unveiled facility but urges researchers not to pursue embryonic research.